With the spread of anthelmintic resistance (AR), endoparasite monitoring consolidates its role for a more sustainable targeting of treatments. A survey on endoparasites in dairy goat farms of north-eastern Italy was conducted to test a monitoring approach based on a farm-tailored sample size. Farm management and parasites control practices were investigated in 20 farms through a questionnaire survey. Further, fecal samples were collected (November 2018–September 2019) from 264 animals from 13 farms and were analyzed individually with a modified McMaster method and subsequently pooled to perform a coproculture. Coccidia (78.4%), gastrointestinal strongyles (37.9%), Strongyloides (28.4%), Skrjabinema (18.9%), Trichuris (8.0%) and Nematodirus/Marshallagia (0.4%) were identified. Abundances were higher for coccidia and gastrointestinal strongyles. Haemonchus (71%) was the dominant gastrointestinal nematode. Pasture and age class resulted in the main risk factors at the multivariable analysis through a negative binomial regression model. Results from farm monitoring indicate that our approach can be a cost-effective decision tool to target treatments more effectively, but farmers need to be educated about the importance of parasitological testing, which is currently scarcely implemented, against the risk of AR.

Peste des petits ruminants (PPR) is one of the most important transboundary diseases of small ruminants. In this study, nasal and oral swabs (n = 24) were collected from sheep (n = 7) and goats (n = 17) with clinical signs in southern Ethiopia in March 2020. PPR virus was isolated on Vero dog cells expressing the signaling lymphocyte activation molecule (VDS) and screened using RT-qPCR. Positive samples were confirmed by conventional RT-PCR followed by sequencing of a partial nucleoprotein (N) gene segment. Results revealed that 54% (n = 13/24) of the tested samples were PPRV-positive Phylogenetic analysis revealed that the viruses belonged to lineage IV and lineage II. The lineage IV viruses were similar, although not identical, to other lineage IV viruses previously reported in Ethiopia and other East African countries while the lineage II viruses have been reported for the first time in Ethiopia showed a high nucleotide identity (99.06%) with the vaccine (Nigeria 75/1) that is currently used in Ethiopia for the prevention of PPR. Further investigations are therefore recommended in order to fully understand the true nature of the lineage II PPRVs in Ethiopia.

No abstract

No abstract